Intravenous Administration of Vitamin B Complex Improves Renal Recovery in Patients With AKI

PHASE4CompletedINTERVENTIONAL
Enrollment

260

Participants

Timeline

Start Date

September 1, 2020

Primary Completion Date

December 30, 2021

Study Completion Date

April 30, 2022

Conditions
Acute Kidney Injury
Interventions
DRUG

Vitamin B Complex

"Patients with established AKI will be randomized to received IV vitamin B complex each 1 hours for 5 consecutive days versus placebo.~Every patients will also received Institution standard of care for AKI"

OTHER

STOP AKI protocol

"STOP AKI protocols includes:~S: identify and treat sepsis. Standard measures should be followed to decrease the risk of infection. Close surveillance to identify early signs of infection with appropriate treatment T: avoid nephrotoxins. Avoidance of drugs harmful to the kidneys (e.g. NSAIDs, gentamicin) Care with intravenous iodinated contrast O: optimize blood pressure and optimize volume status. Avoid dehydration e.g. confused patient. Treat hypovolaemia promptly. Consider with-holding patient anti-hypertensives/diuretics until assessed after major surgery or if patient develops sepsis/hypovolemia P: Prevent harm. Identify the cause promptly and manage appropriately to prevent progression. Prevent complications by instituting prompt therapy. Identify drugs excreted through the kidneys and adjust drug doses promptly if AKI develops. Review fluid management plans to prevent inadequate or excessive intravenous fluid administration"

Trial Locations (1)

0

Hospital Obrero No 2 - C.N.S., Cochabamba

All Listed Sponsors
collaborator

International Society of Nephrology

OTHER

lead

Caja Nacional de Salud

OTHER

NCT04893733 - Intravenous Administration of Vitamin B Complex Improves Renal Recovery in Patients With AKI | Biotech Hunter | Biotech Hunter